A newly published paper demonstrated that CCL20 could facilitate the recruitment and activation of type 3 innate lymphoid cells and thus promote antitumor immunity and enhance tumor sensitivity to immunotherapy in lung cancer [32]. The gene discussed is CCL20; the disease is lung carcinoma.